Tacit Therapeutics is creating RNA-targeting treatments for devastating diseases. By repurposing pre-existing components of human cells, we have created the first broadly-applicable and inherently non-immunogenic means to repair mutated genes.
Location: United States, California, South San Francisco
Employees: 1-10
Total raised: $9.5M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | KdT Ventur... | kdtvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.06.2022 | - | $9.5M | - |